Biodistribution of Nanostructured Lipid Carriers in Mice Atherosclerotic Model.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
26 Sep 2019
Historique:
received: 01 08 2019
revised: 24 09 2019
accepted: 25 09 2019
entrez: 29 9 2019
pubmed: 29 9 2019
medline: 13 2 2020
Statut: epublish

Résumé

Atherosclerosis is a major cardiovascular disease worldwide, that could benefit from innovative nanomedicine imaging tools and treatments. In this perspective, we here studied, by fluorescence imaging in ApoE

Identifiants

pubmed: 31561608
pii: molecules24193499
doi: 10.3390/molecules24193499
pmc: PMC6803849
pii:
doi:

Substances chimiques

Apolipoproteins E 0
Drug Carriers 0
Lipids 0
Matrix Metalloproteinases EC 3.4.24.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Seventh Framework Programme
ID : FP7-NMP-2012-LARGE-6-309820

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Nanomedicine. 2016 Jan;12(1):143-61
pubmed: 26410277
Mol Pharm. 2019 Jun 3;16(6):2265-2277
pubmed: 31063396
Eur J Pharm Biopharm. 2015 Jun;93:1-10
pubmed: 25805562
Nat Nanotechnol. 2013 Feb;8(2):137-43
pubmed: 23334168
EBioMedicine. 2018 Feb;28:225-233
pubmed: 29361501
Arthritis Rheumatol. 2014 Mar;66(3):589-98
pubmed: 24574219
J Thorac Cardiovasc Surg. 2018 May;155(5):2164-2175.e1
pubmed: 29429629
Bioconjug Chem. 2016 Oct 19;27(10):2407-2417
pubmed: 27564088
Nanomedicine (Lond). 2015;10(11):1817-32
pubmed: 26080701
Trends Mol Med. 2014 May;20(5):271-81
pubmed: 24594264
J Colloid Interface Sci. 2011 Aug 15;360(2):471-81
pubmed: 21596385
Drug Deliv. 2010 Sep-Oct;17(7):467-89
pubmed: 20491540
J Clin Invest. 1998 Dec 1;102(11):1900-10
pubmed: 9835614
J Control Release. 2017 Sep 28;262:47-57
pubmed: 28700897
Bioconjug Chem. 2016 Mar 16;27(3):569-75
pubmed: 26751997
Arterioscler Thromb Vasc Biol. 2011 Mar;31(3):528-35
pubmed: 21212406
Mol Cancer Ther. 2009 Oct;8(10):2861-71
pubmed: 19825804
Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):E6731-E6740
pubmed: 27791119
Sci Rep. 2016 Dec 05;6:38345
pubmed: 27917892
Pharm Res. 2010 Aug;27(8):1469-86
pubmed: 20411409
J Biol Chem. 2006 Apr 21;281(16):11152-60
pubmed: 16481329
J Struct Biol. 2013 Jun;182(3):246-54
pubmed: 23567804
Circulation. 2006 Apr 25;113(16):1993-2001
pubmed: 16636188
Nanomedicine (Lond). 2011 Jun;6(4):715-28
pubmed: 21718180
Braz J Med Biol Res. 2018 Jan 23;51(3):1-8
pubmed: 29513883
Curr Drug Deliv. 2016;13(1):4-26
pubmed: 26279117
Adv Drug Deliv Rev. 2008 Mar 17;60(6):757-67
pubmed: 18096269
J Nucl Med. 2013 Nov;54(11):1996-2003
pubmed: 24071507
Curr Opin Lipidol. 2016 Dec;27(6):592-596
pubmed: 27653220
Cardiovasc Drugs Ther. 2016 Oct;30(5):433-443
pubmed: 27628679
Adv Drug Deliv Rev. 2016 Nov 15;106(Pt A):116-131
pubmed: 27133387
Int J Pharm. 2002 Aug 21;242(1-2):121-8
pubmed: 12176234
Eur J Pharm Biopharm. 2016 Mar;100:85-93
pubmed: 26777342
Nat Chem Biol. 2006 May;2(5):274-81
pubmed: 16565715
Mol Pharm. 2019 Feb 4;16(2):756-767
pubmed: 30604620
Drug Dev Ind Pharm. 2014 Dec;40(12):1565-75
pubmed: 24766553
Eur J Pharm Biopharm. 2009 Feb;71(2):161-72
pubmed: 18824097
Prog Lipid Res. 2017 Oct;68:1-11
pubmed: 28778472
Int J Pharm. 2008 Jun 5;357(1-2):295-304
pubmed: 18343059
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15575-80
pubmed: 16221765
Drug Discov Today. 2017 Jan;22(1):180-185
pubmed: 27591840
Int J Cardiol. 2015 Apr 15;185:198-208
pubmed: 25797678
Nat Med. 2014 May;20(5):493-502
pubmed: 24784232
Arterioscler Thromb Vasc Biol. 2016 Mar;36(3):446-55
pubmed: 26769047
Int J Pharm. 2018 Dec 1;552(1-2):328-339
pubmed: 30308270
Adv Drug Deliv Rev. 2001 Apr 25;47(2-3):165-96
pubmed: 11311991
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 Nov;8(6):909-926
pubmed: 27194461
Recent Pat Drug Deliv Formul. 2008;2(2):120-35
pubmed: 19075903
Materials (Basel). 2018 May 08;11(5):null
pubmed: 29738480
Pharm Res. 2014 Oct;31(10):2563-82
pubmed: 24848341
Nat Commun. 2018 Jun 20;9(1):2416
pubmed: 29925830
J Biomed Opt. 2011 Sep;16(9):096013
pubmed: 21950927
AAPS PharmSciTech. 2011 Dec;12(4):1200-8
pubmed: 21927961
Eur J Pharm Biopharm. 2016 Nov;108:235-252
pubmed: 27519829
Curr Drug Discov Technol. 2011 Sep;8(3):207-27
pubmed: 21291409
Eur J Pharm Biopharm. 2014 Aug;87(3):433-44
pubmed: 24833004
Contrast Media Mol Imaging. 2007 Jan-Feb;2(1):16-23
pubmed: 17318917
Pharm Pat Anal. 2014 Mar;3(2):199-215
pubmed: 24588596
J Am Heart Assoc. 2012 Dec;1(6):e001040
pubmed: 23316311
Small. 2018 Jan;14(4):
pubmed: 29239134
Proc Natl Acad Sci U S A. 1987 Oct;84(19):6654-8
pubmed: 3477796

Auteurs

Laurent Devel (L)

CEA, Institut des Sciences du Vivant Frédéric Joliot, Service d'Ingénierie Moléculaire des Protéines (SIMOPRO), Université Paris-Saclay, 91190 Gif-sur-Yvette, France. laurent.devel@cea.fr.

Gunter Almer (G)

Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, 8036 Graz, Austria. gunter.almer@medunigraz.at.

Claudia Cabella (C)

Centro Ricerche Bracco, Bracco Imaging SpA, 10010 Colleretto Giacosa, Italy. claudia.cabella@bracco.com.

Fabrice Beau (F)

CEA, Institut des Sciences du Vivant Frédéric Joliot, Service d'Ingénierie Moléculaire des Protéines (SIMOPRO), Université Paris-Saclay, 91190 Gif-sur-Yvette, France. fabrice.beau@cea.fr.

Mylène Bernes (M)

CEA, Institut des Sciences du Vivant Frédéric Joliot, Service d'Ingénierie Moléculaire des Protéines (SIMOPRO), Université Paris-Saclay, 91190 Gif-sur-Yvette, France. bernesmylene@hotmail.fr.

Paolo Oliva (P)

Centro Ricerche Bracco, Bracco Imaging SpA, 10010 Colleretto Giacosa, Italy.

Fabrice Navarro (F)

University Grenoble Alpes, CEA, LETI, F-38000 Grenoble, France.

Ruth Prassl (R)

Institute of Biophysics, Medical University of Graz, 8036 Graz, Austria.

Harald Mangge (H)

Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, 8036 Graz, Austria.

Isabelle Texier (I)

University Grenoble Alpes, CEA, LETI, F-38000 Grenoble, France. Isabelle.texier-nogues@cea.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH